CCO stock advances as Cameco backs 2025 uranium outlook

Cameco stock advances as the uranium producer continues to anchor its case on long-term contracted demand and a tighter supply backdrop. Cameco Corp. (CA13321L1085) said in its investor materials that 31.0 million pounds of uranium were expected to be purchased under long-term commitments in 2025, while 2024 revenue reached C$1.2 billion and adjusted EBITDA was C$151 million.

31.0 million pounds

The 31.0 million-pound contract figure is the clearest near-term operating marker in the latest Cameco investor context. It shows how much of the business is still tied to committed supply, a structure that matters more to Cameco than spot-price chatter.

The same company materials put 2024 revenue at C$1.2 billion, up from the prior year base embedded in the annual reporting package, while adjusted EBITDA came in at C$151 million for 2024. Cameco also reported a US$56 million adjusted net loss for 2024, a reminder that earnings can remain volatile even when contract volumes are large.

2024 earnings stay uneven

For investors, the comparison is the point: C$1.2 billion of revenue and C$151 million of adjusted EBITDA were not presented as a breakout year, but as a step in a longer uranium cycle. The US$56 million adjusted net loss shows that the company is still balancing contract economics, production timing and market pricing.

The investor materials also framed future purchases and deliveries around long-term commitments rather than a single quarter. That makes the 31.0 million-pound figure more useful than a short-lived price move because it describes demand visibility into 2025.

Uranium contracts drive the story

The product line most relevant here is uranium itself, because Cameco's sales model is built around long-term supply agreements and market-linked deliveries. The latest company update centers on contract coverage, not on consumer demand or brand-led growth.

That focus matters because uranium pricing and contract timing feed directly into revenue timing, EBITDA and reported profitability. When 31.0 million pounds are already spoken for under long-term commitments, the market tends to look past headline volatility and toward execution.

Market context and price level

As of 16 July 2026, Cameco stock was trading on the Toronto Stock Exchange under the CAD quote used for the Canadian listing context, with the market watching the contract book and the 2024 earnings base rather than a single trading session. The key market reference remains the 31.0 million-pound 2025 purchase commitment, alongside 2024 revenue of C$1.2 billion and adjusted EBITDA of C$151 million.

That combination gives Cameco a story built on visible supply commitments, a still-cyclical earnings profile and a uranium cycle that remains central to the share price narrative.

Uranium sales and reporting mix

Cameco's uranium sales and reporting mix are the core product references for the stock. The company materials place long-term contracted volumes first, then connect them to the 2024 revenue and EBITDA figures.

Stock level and listing

As of 16 July 2026, the relevant market context is Cameco's Toronto listing and the Canadian dollar denomination used in the company reporting package. The stock story is therefore tied to contract visibility, 2024 revenue of C$1.2 billion and adjusted EBITDA of C$151 million rather than to a one-off catalyst.